「Analysis of radiotherapy-induced alterations of CD8+ T cells and PD-L1 expression in patients with uterine cervical squamous cell carcinoma」の関連論文
-
がん治療用ウイルスG47Δを用いた肝細胞癌・膵癌の新治療法の開発
-
レンバチニブによる肝細胞がんの腫瘍血管正常化と放射線増感効果の研究
-
Soluble podoplanin as biomarker in diffuse-type gastric cancer
-
S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model
-
Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma
-
膵腺癌切除後の肺再発の臨床病理学的特徴とリスク因子
-
The pathological complete response and secreted protein acidic and rich in cysteine expression in patients with breast cancer receiving neoadjuvant nab-paclitaxel chemotherapy
-
Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival
-
抗アポトーシス因子Stanniocalcin-1を標的とした新たな肺がん治療法に関する基礎的研究
-
光線免疫療法の消化器腫瘍への応用にむけた基礎的検討
-
肺がんの進展における免疫抑制性受容体LILRB4の役割についての検討
-
The Prognostic Significance of Peritumoral Lymphocytes’ Band-like Structure in Type II Endometrial Cancer
-
マウス扁平上皮癌顎骨浸潤モデルにおける Interleukin-12 発現型第三世代がん治療用 HSV-1 投与効果の検討
-
大腸癌放射線療法におけるmTOR経路とオートファジーの活性化
-
初発単発肝細胞癌に対する肝切除と粒子線治療成績の比較:2施設間での傾向スコアマッチング解析を用いた検討
-
The blockade of interleukin-33 released by hepatectomy would be a promising treatment option for cholangiocarcinoma
-
腹膜播種陽性または腹腔細胞診陽性の胃癌に対する集学的治療の開発
-
肺腺癌におけるOvarian cancer immuno-reactive antigen domain containing 2 (OCIAD2) 発現の臨床病理学的意義および機能解析
-
Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: A prospective study
-
Expression of hemoglobin beta is associated with poor prognosis and aggressive phenotypes in clear cell renal cell carcinoma
-
Study on the clinical outcome and molecular changes of precursor-targeted immune-mediated anemia treated with splenectomy [an abstract of entire text]
-
肝外胆管癌におけるInflammation-Based Scoresの予後への影響
-
がん治療用ウイルスの胆道癌治療への応用と新規機能付加型HSV-1の開発
-
Neoadjuvant CAPOX and bevacizumab alone for locally advanced rectal cancer: long-term results from the N-SOG 03 trial
-
Molecular profiling of circulating tumor cells predicts clinical outcome in head and neck squamous cell carcinoma
-
Occult synchronous liver metastasis from perihilar cholangiocarcinoma
-
膵がん細胞表面糖鎖を標的とした治療法の開発-レクチンを用いた光線療法-
-
Drug library screening identifies histone deacetylase inhibition as a novel therapeutic strategy for choriocarcinoma
-
腎代替療法実施患者の感染モニタリングと新規の腎移植免疫抑制薬候補化合物に関する研究
-
Efficacy and Safety of Sorafenib in Unresectable Hepatocellular Carcinoma with Bile Duct Invasion
-
Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer
-
Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non-small cell lung cancer
-
リガンド搭載ナノ製剤による難治性頭頸部扁平上皮癌に対する治療効果に関する研究
-
低腫瘍量濾胞性リンパ腫における遺伝子発現に基づく新規予後予測モデルの構築
-
Interleukin‑33 expression in ovarian cancer and its possible suppression of peritoneal carcinomatosis
-
化学療法後の大腸癌肝転移におけるMRIを用いた腫瘍内脂質検出の臨床的意義
-
Immunohistological evaluation of mismatch repair deficiency in pancreatic ductal adenocarcinoma treated with surgical resection
-
Immunohistological evaluation of mismatch repair deficiency in pancreatic ductal adenocarcinoma treated with surgical resection
-
Overexpression of KIAA1199, a novel strong hyaluronidase, is a poor prognostic factor in patients with osteosarcoma
-
Microenvironmental Impact on Tumour Cell Phenotype and Genotype in Adult and Paediatric Tumours
-
局所進行頭頸部扁平上皮癌における予防的リンパ節照射線量の検討:プロペンシティスコア・マッチング解析
-
切除不能初発肝内胆管癌に対する陽子線治療の成績の解析
-
結腸癌術後腹膜播種再発の臨床病理学的特徴とリスク予測に関する検討
-
BEX2は胃がんにおける予後不良因子でありがん幹細胞性を亢進させる
-
PLD1 promotes tumor invasion by regulation of MMP-13 expression via NF-κB signaling in bladder cancer
-
Efficacy and safety of accelerated fractionated radiotherapy without elective nodal irradiation for T3N0 glottic cancer without vocal cord fixation
-
Wnt経路を標的とした悪性骨腫瘍の病態解析とスクレロスチンによる治療の臨床応用
-
Role of resection for extrahepatopulmonary metastases of colon cancer
-
免疫チェックポイント阻害薬使用患者の癌種横断的レジストリの構築、ならびに治療効果・免疫関連有害事象発現の予測に関する研究
-
<学会抄録>第70回日本泌尿器科学会中部総会